Abstract
Wee1 kinase downregulates the M-phase promoting factor, a complex of cdc2 and cyclin B kinase, that controls mitotic cell division. We isolated human wee1 kinase gene promoter and found that it contained one AP-1-binding motif in its promoter region (5′-CGAGTCA-3′; −823/−817), through which wee1 kinase gene was directly transactivated by c-Fos/AP-1. In rheumatoid synovial cells, wee1 kinase was increased in conjunction with the increase of c-Fos/AP-1 and the substrate of wee1, cdc2, was phosphorylated. The amount of wee1 and c-Fos and the phosphorylation of cdc2 were decreased after treatment of the cells with an inhibitor of AP-1, curcumin. A significant proportion of cultured synovial cells of the patients with rheumatoid arthritis, but not those of osteoarthritis, shifted to a tetraploid (4C) state upon long-term culture. Thus, human wee1 kinase gene is directly transactivated by and increased in association with c-Fos/AP-1, and rheumatoid synovial cells overexpressing these genes go into aberrant mitosis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Abbreviations
- DIG:
-
digoxigenin
- EMSA:
-
electrophoretic mobility shift assay
- MPF:
-
M-phase promoting factor
- OA:
-
osteoarthritis
- PCNA:
-
proliferating cell nuclear antigen
- PMA:
-
phorbol 12-myristate 13-acetate
- RA:
-
rheumatoid arthritis
- TSS:
-
transcription start sit
References
Aicher WK, Heer AH, Trabandt A, Bridgee Jr SL, Schroeder Jr HW, Stransky G, Gay RE, Eibel H, Peter HH, Siebenlist U, Koopman WJ and Steffen G . (1994). J. Immunol., 152, 5940–5948.
Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger Jr TA, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL and Hunder GG . (1988). Arthritis Rheum., 31, 315–324.
Asahara H, Fujisawa K, Kobata T, Hasunuma T, Maeda T, Asanuma M, Ogawa N, Inoue H, Sumida T and Nishioka K . (1997). Arthritis Rheum., 40, 912–918.
Broek D, Bartlett R, Crawford K and Nurse P . (1991). Nature, 349, 388–393.
Chinenov Y and Kerppola TK . (2001). Oncogene, 20, 2438–2454.
Fassbender HG . (1984). Arthritis Rheum., 27, 956.
Fassbender HG . (1998). Arth. Orthop. Trauma Surg., 117, 2–7.
Gould KL and Nurse P . (1989). Nature, 342, 39–45.
Hartwell LH and Kastan MB . (1994). Science, 266, 1821–1828.
Hino K, Shiozawa S, Kuroki Y, Ishikawa H, Shiozawa K, Sekiguchi K, Hirano H, Sakashita E, Miyashita K and Chihara K . (1995). Arthritis Rheum., 38, 678–683.
Hung TS, Kuo ML, Lin JK and Hsieh JSC . (1995). Cancer Lett., 96, 1–7.
Jacobs RA, Perrett D, Axon JM, Herbert KE and Scott DL . (1995). Clin. Exp. Rheumatol., 13, 717–723.
Kaker SS and Roy D . (1994). Cancer Lett., 87, 85–89.
Kawasaki H, Komai K, Ouyang Z, Murata M, Hikasa M, Ohgiri M and Shiozawa S . (2001). EMBO J., 20, 4618–4627.
Kawasaki H, Nakata Y, Suzuki G, Chihara K, Tokuhisa T and Shiozawa S . (1999). Int. Immunol., 11, 1873–1880.
Kuroki Y, Shiozawa S, Sugimoto T, Kanatani M, Kaji H, Miyachi A and Chihara K . (1994). Clin. Exp. Immunol., 95, 536–539.
Kuroki Y, Shiozawa S, Yoshihara R and Hotta H . (1993). J. Rheumatol., 20, 422–428.
Mohan R, Sivak J, Ashton P, Russo LA, Pham BQ, Kasahara N, Raizman MB and Fini ME . (2000). J. Biol. Chem., 275, 10405–10412.
Morgan DO . (1995). Nature, 374, 131–134.
Norbury C, Blow J and Nurse P . (1991). EMBO J., 10, 3321–3329.
Nurse P . (1990). Nature, 344, 503–508.
Piechaczyk M and Blanchard JM . (1994). Crit. Rev. Oncol. Hematol., 17, 93–131.
Pope RM, Lovis R, Mungre S, Perlman H, Koch AE and Haines III GK . (1999). Clin. Immunol., 91, 271–282.
Russell P and Nurse P . (1987). Cell, 49, 559–567.
Schaser K, Kinne RW, Beil H, Kladny B and Stoss H . (1996). Verh. Dtsch. Ges. Pathol., 80, 276–280.
Secchiero P, Bertolaso L, Casareto L, Gibellini D, Vitale M, Bemis K, Aleotti A, Capitani S, Franchini G, Gallo RC and Zauli G . (1998). Blood, 92, 1685–1696.
Shaulian E and Karin M . (2001). Oncogene, 20, 2390–2400.
Shiozawa S, Shimizu K, Tanaka K and Hino K . (1997). J. Clin. Invest., 99, 1210–1216.
Shiozawa S, Shiozawa K and Fujita T . (1983). Arthritis Rheum., 26, 472–478.
Shiozawa S, Tanaka Y, Fujita T and Tokuhisa T . (1992). J. Immunol., 148, 3100–3104.
Strausfeld U, Labbe JC, Fesquet D, Cavadore JC, Picard A, Sadhu K, Russell P and Doree M . (1991). Nature, 351, 242–245.
Trabant A, Aicher WK, Gay RE, Sukhatme VP, Fassbender HG and Gay S . (1992). Rheumatol. Int., 12, 53–59.
Wakisaka S, Suzuki N, Takeno M, Takebe Y, Nagafuchi H, Saito N, Hashimoto H, Tomita T, Ochi T and Sakane T . (1998). Ann. Rheum. Dis., 57, 487–497.
Yamanishi Y and Firestein GS . (2001). Rheum. Dis. Clin. North Am., 27, 355–371.
Zhang Y, Wang Z and Ravid K . (1996). J. Biol. Chem., 271, 4266–4271.
Acknowledgements
We thank Dr M Lamphier for critical reading of the manuscript. This work was supported in part by the grant-in-aid for scientific research to SS (B) 07557228, (B) 08457153, (B) 09470127 and (B) 11557026 of the Ministry of Education, Science, Sports and Culture.
Nucleotide data: Nucleotide sequence data of human wee1 promoter region are available in the DDBJ/EMBL/GenBank databases under the accession number AB019581.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kawasaki, H., Komai, K., Nakamura, M. et al. Human wee1 kinase is directly transactivated by and increased in association with c-Fos/AP-1: rheumatoid synovial cells overexpressing these genes go into aberrant mitosis. Oncogene 22, 6839–6844 (2003). https://doi.org/10.1038/sj.onc.1206903
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1206903
Keywords
This article is cited by
-
Pathogenesis of Joint Destruction in Rheumatoid Arthritis
Archivum Immunologiae et Therapiae Experimentalis (2011)
-
Treatment of arthritis with a selective inhibitor of c-Fos/activator protein-1
Nature Biotechnology (2008)
-
Silencing of human Int-6 impairs mitosis progression and inhibits cyclin B–Cdk1 activation
Oncogene (2005)